WO2023187691 - METHODS OF PURIFYING AN ENVELOPED VIRUS
National phase entry:
Publication Number
WO/2023/187691
Publication Date
05.10.2023
International Application No.
PCT/IB2023/053159
International Filing Date
30.03.2023
Title **
[English]
METHODS OF PURIFYING AN ENVELOPED VIRUS
[French]
PROCÉDÉS DE PURIFICATION D'UN VIRUS ENVELOPPÉ
Applicants **
CSL BEHRING LLC
Inventors
BRANDT, Tobias
LAUX, Holger
VOGEL, Jessica Elisabeth
Priority Data
63/362,163
30.03.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4035 | |
| EPO | Filing, Examination, Granting | 60620 | |
| Japan | Filing, Examination, Granting | 3972 | |
| South Korea | Filing, Examination, Granting | 6057 | |
| USA | Filing, Examination, Granting | 15710 |
Total:
90,394
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates generally to the manufacturing of gene therapy products, and specifically to methods of purifying an enveloped virus from a cell culture fluid, comprising an endonuclease and/or anion exchange chromatography.[French]
La présente invention concerne de manière générale la fabrication de produits de thérapie génique, et spécifiquement des procédés de purification d'un virus enveloppé contenu dans un fluide de culture cellulaire, comprenant une endonucléase et/ou une chromatographie d'échange d'anions.